Summary
UnitedHealth Group (UNH) reported a strong first quarter for 2019, demonstrating robust revenue growth and significant increases in earnings. Total revenues rose by 9% year-over-year to $60.3 billion, driven by an 8% increase in UnitedHealthcare revenues and a substantial 12% growth in Optum revenues. This top-line performance translated into a 19% increase in earnings from operations to $4.8 billion, and a 22% rise in net earnings attributable to common shareholders to $3.5 billion. Diluted earnings per share also saw a healthy increase of 24% to $3.56. The company's operational efficiency improved, with a decrease in the operating cost ratio and an increase in operating margin. UnitedHealthcare served approximately 880,000 more people, primarily due to growth in Medicare Advantage and self-funded employer services. Optum's diversified businesses, including OptumHealth, OptumInsight, and OptumRx, all contributed positively to revenue and earnings growth. The company maintained a strong balance sheet with significant cash and investment balances, and a healthy return on equity of 26.8%.
Financial Highlights
53 data points| Revenue | $60.31B |
| Cost of Revenue | $7.38B |
| Gross Profit | $52.93B |
| SG&A Expenses | $8.52B |
| Operating Expenses | $55.48B |
| Operating Income | $4.83B |
| Interest Expense | $400.00M |
| Net Income | $3.47B |
| EPS (Basic) | $3.62 |
| EPS (Diluted) | $3.56 |
| Shares Outstanding (Basic) | 958.00M |
| Shares Outstanding (Diluted) | 975.00M |
Key Highlights
- 1Total revenues increased 9% to $60.3 billion compared to the prior year's first quarter.
- 2Net earnings attributable to UnitedHealth Group common shareholders grew 22% to $3.5 billion.
- 3Diluted earnings per share increased by 24% to $3.56.
- 4UnitedHealthcare served 880,000 additional people, with significant growth in Medicare Advantage.
- 5Optum revenues grew 12%, driven by strong performance across its sub-segments (OptumHealth, OptumInsight, OptumRx).
- 6Earnings from operations increased by 19% to $4.8 billion.
- 7Return on Equity improved to 26.8% from 23.8% in the prior year.